(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIVING HYPOPARA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

LIVING HYPOPARA

ST13

US500000098041740

Class

9, 41, 44

Filing

98041740

Registration

8055223

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

12/09/2025

Classification

Registered

Trademark type

Combined

Nice classes

9, 41, 44

Filing date

06/14/2023

Registration date

12/09/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/09/2025

Last transaction

12/09/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

99

Owner location

Hellerup, DK

Examiner

TWAY, TATIANA R

Law office

L50

Current location

INTENT TO USE SECTION

Mark description

The mark consists of the wording "LIVING HYPOPARA" in blue text with the word "LIVING" inside a yellow shaded circle.

Holders and representatives

Holders

Ascendis Pharma Endocrinology Division A/S

Representatives

Shannon Marie McKeon DYKEMA GOSSETT PLLC

Technical classification

Nice Classes

Class 9Class 41Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable computer software and downloadable computer application software for use in providing medical advice and advice on medications for treatmentpatient assistance and health insurance in the field of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersa downloadable software application for sharing information related to hypoparathyroidismgrowth disordersendocrine disorders and bone disorders and the treatment of hypoparathyroidismgrowth disordersendocrine disordersbone disorders for use by patients with growth hormone disordershypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders

Class 41

Educational and teaching servicesproviding conferencessymposiumsseminarsworkshopslecturesclasses and online education seminars in the field of pharmaceuticalsmedicinehealth care; Publication of non-downloadable electronic publications in the nature of advisory board reportsmagazinesjournals and articles in the field of pharmaceuticalmedical and healthcare topics; Editorial reporting services; News syndication reporting; Educational servicesconducting educational programs for patients and healthcare providers related to hypoparathyroidismgrowth disordersendocrine disorders and bone disorders and the treatment of hypoparathyroidismgrowth disordersendocrine disordersbone disorders for use by patients with growth hormone disordershypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders

Class 44

Providing and sharing of medical information and advice relating to growth hormone deficiencyendocrinological disordersbone and skeletal disordersdiagnosis and treatmentmedical screeningmedicinehealth and pharmaceutical products; Patient support programproviding health care information to patients and healthcare providers in the field of growth hormone deficiencyendocrine disordersbone and skeletal disorders diagnosis and treatment including providing information on self-administering medications; Providing an online website featuring medical and healthcare information related to hypoparathyroidismgrowth disordersendocrine disorders and bone disorders and the treatment of hypoparathyroidismgrowth disordersendocrine disordersbone disorders for use by patients with growth hormone disordershypoparathyroidism and skeletal dysplasia in the medical field of hypoparathyroidismgrowth disordersendocrine disorders and bone disorders

Publications

History of USPTO decisions and trademark events.

34 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/09/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/09/2025

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

11/13/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/10/2025

IUCN

NOTICE OF ALLOWANCE CANCELLED

07/02/2025

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

07/02/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/10/2024

PUBO

PUBLISHED FOR OPPOSITION

12/10/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/04/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/18/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/06/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/06/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

11/06/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

10/21/2024

GNFR

FINAL REFUSAL E-MAILED

10/21/2024

CNFR

FINAL REFUSAL WRITTEN

10/21/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/27/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/27/2024

ALIE

ASSIGNED TO LIE

09/26/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

05/30/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

05/29/2024

GNSL

LETTER OF SUSPENSION E-MAILED

05/29/2024

CNSL

SUSPENSION LETTER WRITTEN

05/29/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/17/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/17/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/17/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/21/2024

GNRT

NON-FINAL ACTION E-MAILED

02/21/2024

CNRT

NON-FINAL ACTION WRITTEN

02/21/2024

DOCK

ASSIGNED TO EXAMINER

02/14/2024

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/19/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/18/2023

NWAP

NEW APPLICATION ENTERED

06/17/2023

Continuous trademark protection

Get notified about every new filing that threatens LIVING HYPOPARA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.